WWW - Posts tagged Bristol Meyers at BloggingStocks

Bristol-Meyers posts

Earnings highlights: Yahoo!, McDonald's, American Express, Pfizer, Delta and others

Posted Feb 1st 2009 9:40AM by Trey Thoelcke (RSS feed)
Filed under: Earnings Reports, Yahoo! (YHOO), Pfizer (PFE), Home Depot (HD), McDonald's (MCD), American Express (AXP), Best Buy (BBY), Bristol-Myers Squibb (BMY), Colgate-Palmolive (CL), Texas Instruments (TXN), Valero Energy (VLO), Eaton Corp (ETN), Delta Air Lines (DAL)

Here are some highlights from this past week's earnings coverage from BloggingStocks:

American Express Co. (NYSE: AXP) earnings tumbled in Q4 but came in just short of expectations.
Best Buy Inc. (NYSE: BBY) earnings prospects and cash flow led to an analyst's upgrade.
Bristol-Myers Squibb Co. (NYSE: BMY) topped analysts Q4 expectations, sending shares higher.
Colgate-Palmolive Co. (NYSE: CL) posted a better-than-expected Q4 profit despite the weak economy.
Delta Air Lines Inc. (NYSE: DAL) reported a big quarterly loss due to merger costs and bad fuel hedges.
Eaton Corp. (NYSE: ETN) Q4 earnings fell on lower exchange rates and charges related to an acquisition.
E*Trade Financial Corp. (NASDAQ: ETFC) narrowed its Q4 net loss but fell short of expectations.

Continue reading Earnings highlights: Yahoo!, McDonald's, American Express, Pfizer, Delta and others

Bristol-Meyers gears for Plavix rival

Posted Aug 8th 2006 2:45PM by Michael Canfield (RSS feed)
Filed under: SEC Filings, Good news, Bad News, Industry, Competitive Strategy

Bristol-Myers Squibb (BMY) is expecting a competitor to produce a generic version of their popular drug Plavix, and is putting out the word it will vigorously defend its patent rights in the United States and abroad, they said in their quarterly filing with the SEC.

Shares fell $1.56, or 6.9%, to $21.21 in premarket activity after the comments were made. This follows a rough couple weeks for BMY as shares have dropped over 12% since the launching of a investigation in alleged anti-trust activity around this same drug. [The shares have remained at about $20.20 most of the day.]

Plavix is a blood thinner. The needs of public who can benefit from less expensive drugs, and of the companies that seek profits and funds for expensive and speculative R&D, is just about the thorniest issue in capitalism that I can think of. Sooner or later, every drug that proves useful gets knocked off.

Michael Canfield doesn't own stock in Bristol-Myers.